Detalhe da pesquisa
1.
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study.
Mol Cancer
; 23(1): 64, 2024 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38532456
2.
Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma.
J Hepatol
; 80(2): 322-334, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37972659
3.
Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal Cancers.
Oncologist
; 29(6): 493-503, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38330461
4.
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.
Oncologist
; 29(4): e514-e525, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297981
5.
Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers.
Hepatology
; 78(3): 758-770, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999533
6.
Revisiting the Malignant Masquerade at the Liver Hilum: Have We Made Progress?
Ann Surg Oncol
; 31(5): 3062-3068, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38282027
7.
A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF-10502-01 for the treatment of advanced solid tumors.
Cancer
; 129(10): 1537-1546, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36882377
8.
Effects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Randomized Clinical Trial.
Ann Surg
; 278(1): 22-30, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37026453
9.
Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of FGFR-Aberrant Tumors.
Oncologist
; 28(11): 928-943, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37390492
10.
Palliative Rehabilitation in Acute Inpatient Rehabilitation: Prognostic Factors and Functional Outcomes in Patients with Cancer.
Oncologist
; 28(2): 180-186, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36367387
11.
Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis.
Oncologist
; 28(4): 327-332, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36715178
12.
The immunogenomic landscape of resected intrahepatic cholangiocarcinoma.
Hepatology
; 75(2): 297-308, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34510503
13.
NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma.
Ann Surg Oncol
; 30(11): 6558-6566, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37368098
14.
Neoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma - does pathologic response mean better outcomes?
HPB (Oxford)
; 25(4): 472-480, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36781357
15.
Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States.
Cancer
; 128(13): 2529-2539, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35417569
16.
Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma.
Am J Transplant
; 22(3): 823-832, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34856069
17.
Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017.
Oncologist
; 27(10): 874-883, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35972334
18.
Radiographic and Serologic Response to First-Line Chemotherapy in Unresected Localized Pancreatic Cancer.
J Natl Compr Canc Netw
; 20(8): 887-897.e3, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35948035
19.
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study.
Lancet Oncol
; 22(9): 1290-1300, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34339623
20.
Genomic profiling of multifocal intrahepatic cholangiocarcinoma reveals intraindividual concordance of genetic alterations.
Carcinogenesis
; 42(3): 436-441, 2021 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33200197